Dr. Aladdin H. Shadyab is an Assistant Professor of Epidemiology in the Herbert Wertheim School of Public Health and Human Longevity Science at the University of California, San Diego. Dr. Shadyab’s research focuses on geroscience, biological aging, longevity, and Alzheimer's disease and related dementias. Dr. Shadyab's robust research program is funded by the National Institute on Aging (NIA). He is Principal Investigator on an NIA-funded R01 (RF1AG074345) to identify epigenetic aging biomarkers for mild cognitive impairment, Alzheimer's disease and related dementias, cognitively healthy longevity, and brain aging. He has expertise in the recruitment of patients with mild cognitive impairment or Alzheimer's disease into pharmacologic and lifestyle intervention clinical trials, including both industry-sponsored and NIH-funded trials, and has published papers on the most effective approaches for recruitment of patients across the spectrum of Alzheimer's disease into clinical trials. Dr. Shadyab has authored 130 scientific publications on aging and the health of older adults in prestigious journals including Alzheimer's & Dementia, Neurology, JAMA, Annals of Internal Medicine, American Journal of Public Health, and American Journal of Epidemiology.